{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T18:41:15Z","timestamp":1776969675009,"version":"3.51.4"},"reference-count":49,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Healthc Risk Manag"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>The study aims to proactively analyze the chemotherapy drug management process, focusing on the nursing role: identifying error modes and proposing improvement interventions. A quality improvement project was conducted at an Onco\u2010Hematological Department, applying a systematic and prospective approach to evaluate the critical phases of the chemotherapy drug process. A risk analysis was conducted using Failure Mode, Effects, and Criticality Analysis (FMECA). A multidisciplinary team of healthcare professionals with experience in the sector mapped the process, identified potential failure modes, calculated the Risk Priority Numbers (RPNs), and implemented corrective actions. The RPNs were re\u2010evaluated after three months to measure intervention effectiveness. The analysis identified eight error modes, two of which were classified as high risk: contamination (initial RPN 27) and inaccurate dosing (initial RPN 24). After the implementation of improvement actions, such as specific training and formalized double checking, the RPNs were reduced to 4 and 3, respectively, with an improvement greater than 85%. The application of FMECA has allowed for effective identification and mitigation of the main risks associated with chemotherapeutic drug management, contributing to improve patient safety and nurse perceived quality of performance, through a model replicable in other healthcare settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jhrm.70021","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T10:31:37Z","timestamp":1772965897000},"page":"5-13","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proactive risk assessment and nursing risk management in chemotherapy drugs: FMECA methodology results"],"prefix":"10.1002","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0299-6145","authenticated-orcid":false,"given":"Gennaro","family":"Laus","sequence":"first","affiliation":[{"name":"IRCCS CROB  Rionero in Vulture Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8179-1072","authenticated-orcid":false,"given":"Giuseppe","family":"Bertozzi","sequence":"additional","affiliation":[{"name":"CIS of Legal Medicine of Basilicata Potenza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7362-260X","authenticated-orcid":false,"given":"Aldo","family":"Di Fazio","sequence":"additional","affiliation":[{"name":"CIS of Legal Medicine of Basilicata Potenza Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-0098","authenticated-orcid":false,"given":"Federico","family":"Ruta","sequence":"additional","affiliation":[{"name":"General Direction ASL BAT  Barletta Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6330-806X","authenticated-orcid":false,"given":"Tommaso","family":"Cassano","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences University of Foggia  Foggia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8328-5191","authenticated-orcid":false,"given":"Sipontina Rita","family":"Zerulo","sequence":"additional","affiliation":[{"name":"University of Foggia Foggia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"e_1_2_21_2_1","unstructured":"Ministero della Salute.Raccomandazione per la prevenzione della morte coma o grave danno derivati da errori in terapia farmacologica.2008.https:\/\/buonepratiche.agenas.it\/documents\/recommendations\/Racc.07_Farmaci.pdf"},{"key":"e_1_2_21_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470\u20102045(18)30094\u20109"},{"key":"e_1_2_21_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192416430"},{"key":"e_1_2_21_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102125.2009.03428.x"},{"key":"e_1_2_21_6_1","doi-asserted-by":"publisher","DOI":"10.4172\/2167\u20101052.1000134"},{"issue":"11","key":"e_1_2_21_7_1","first-page":"771","article-title":"The effect of information provision on reduction of errors in intravenous drug preparation and administration by nurses in ICU and surgical wards","volume":"50","author":"Abbasinazari M","year":"2012","journal-title":"Acta Med Iran"},{"key":"e_1_2_21_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140\u20106736(17)31047\u20104"},{"key":"e_1_2_21_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv032"},{"key":"e_1_2_21_10_1","unstructured":"World Health Organization.Medication safety webinar series: WHO global patient safety challenge: medication without harm & world patient safety day 2022.2022.https:\/\/www.who.int\/news\u2010room\/events\/detail\/2022\/02\/08\/default\u2010calendar\/medication\u2010safety\u2010webinar\u2010series\u2010third\u2010global\u2010patient\u2010safety\u2010challenge\u2010medication\u2010without\u2010harm\u2010world\u2010patient\u2010safety\u2010day\u20102022"},{"key":"e_1_2_21_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102354.2009.01127.x"},{"issue":"1","key":"e_1_2_21_12_1","first-page":"146","article-title":"Chemotherapy safe handling through educating nurses: a pre\u2010experimental study","volume":"8","author":"Mishra R","year":"2021","journal-title":"Int J Cancer Clin Res"},{"key":"e_1_2_21_13_1","volume-title":"To Err is Human: Building a Safer Health System","author":"Kohn LT","year":"2000"},{"key":"e_1_2_21_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs\u20102013\u2010002118"},{"key":"e_1_2_21_15_1","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2001.6519"},{"key":"e_1_2_21_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/jep.13317"},{"key":"e_1_2_21_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/10781552221135130"},{"key":"e_1_2_21_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj\u20102019\u2010137484"},{"key":"e_1_2_21_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2020.1766691"},{"key":"e_1_2_21_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/qhc.13.4.265"},{"key":"e_1_2_21_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155220962189"},{"key":"e_1_2_21_22_1","doi-asserted-by":"crossref","unstructured":"CerroneV AlibertiSM PrendinA et\u00a0al.How patient safety culture influences adverse event reporting and use of the incident reporting tool: a systematic review. Preprints.2023. doi:10.20944\/preprints202307.2011.v1","DOI":"10.20944\/preprints202307.2011.v1"},{"key":"e_1_2_21_23_1","doi-asserted-by":"publisher","DOI":"10.21037\/jhmhp\u201020\u201057"},{"key":"e_1_2_21_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cor.2008.05.002"},{"key":"e_1_2_21_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40545\u2010023\u201000512\u20109"},{"key":"e_1_2_21_26_1","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2015.16.5.1699"},{"key":"e_1_2_21_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm\u20102020\u2010002440"},{"key":"e_1_2_21_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20064952"},{"key":"e_1_2_21_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm\u20102019\u2010001987"},{"key":"e_1_2_21_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264\u2010016\u20100410\u20104"},{"key":"e_1_2_21_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212473000"},{"key":"e_1_2_21_32_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp160948"},{"key":"e_1_2_21_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jep.12468"},{"key":"e_1_2_21_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4188"},{"key":"e_1_2_21_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/jop.17.00007"},{"key":"e_1_2_21_36_1","doi-asserted-by":"publisher","DOI":"10.4103\/jpp.JPP_61_18"},{"key":"e_1_2_21_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2014.05.007"},{"key":"e_1_2_21_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12529"},{"key":"e_1_2_21_39_1","doi-asserted-by":"publisher","DOI":"10.7748\/ns.30.35.61.s49"},{"key":"e_1_2_21_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina60060903"},{"key":"e_1_2_21_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare12'050549"},{"key":"e_1_2_21_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/10781552231151693"},{"key":"e_1_2_21_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/jop.2017.020842"},{"key":"e_1_2_21_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs\u20102019\u2010010206"},{"key":"e_1_2_21_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm\u20102013\u2010000276.175"},{"key":"e_1_2_21_46_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1r147"},{"key":"e_1_2_21_47_1","unstructured":"Ministero della Salute.Recommendation for the prevention of errors in therapy with antineoplastic drugs.2012.https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_1861_allegato.pdf"},{"key":"e_1_2_21_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11845\u2010017\u20101556\u20105"},{"key":"e_1_2_21_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/58.19.1835"},{"key":"e_1_2_21_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11096\u2010020\u201000992\u20108"}],"container-title":["Journal of Healthcare Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jhrm.70021","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jhrm.70021","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jhrm.70021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:59:22Z","timestamp":1776967162000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jhrm.70021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1002\/jhrm.70021"],"URL":"https:\/\/doi.org\/10.1002\/jhrm.70021","archive":["Portico"],"relation":{},"ISSN":["1074-4797","2040-0861"],"issn-type":[{"value":"1074-4797","type":"print"},{"value":"2040-0861","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"2025-07-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}